Streetbeat News

Partnerships

SCYX

SCYNEXIS has entered into a binding Memorandum of Understanding (MoU) to amend its license agreement with GSK. Under the amendment, GSK is granted a royalty-bearing license to develop, manufacture, and commercialize Ibrexafungerp, including the approved product BREXAFEMME, in all countries except Greater China and others already licensed. Details of the agreement are disclosed in SCYNEXIS's Form 8-K dated March 30, 2023.

Portfolio Pulse from Benzinga Newsdesk

January 02, 2024 | 9:13 pm

GDRX

LBPH

MRNA

MSTR

RIVN

VYGR

Longboard Pharmaceuticals, Inc. (LBPH) shares soared by approximately 200% after announcing positive topline data from their PACIFIC Phase 1b/2a study of bexicaserin (LP352) for seizures associated with Developmental and Epileptic Encephalopathies (DEEs). Other stocks experienced significant movement in Tuesday's mid-day session, with various companies seeing substantial gains or losses.

Portfolio Pulse from Avi Kapoor

January 02, 2024 | 6:35 pm

HSKA

VNRX

VolitionRx Limited received $13M in milestone payments from Heska Corporation as part of their License and Supply Agreement. The payment was for the successful transfer of the Nu.Q Vet Cancer Test to Heska's Element i+ Immunodiagnostic Analyzer, now called the 'Heska Nu.Q Vet Canine Cancer Screen and Monitor' test.

Portfolio Pulse from Benzinga Newsdesk

January 02, 2024 | 4:43 pm

SNES

SenesTech, Inc. (NASDAQ:SNES) shares surged after announcing an expanded distribution agreement with Pesterminators Pvt Ltd, which includes the introduction of SenesTech's Evolve and market expansion into the UAE through Pesterminators' subsidiary, TCS Global for General Trading LLC. The expansion is part of SenesTech's regional growth strategy, following the successful integration of their ContraPest products in the Maldives. The agreement includes an initial stocking order for Evolve and an expanded territory that now includes the UAE. SNES shares rose 25.1% to $1.59.

Portfolio Pulse from Akanksha Bakshi

January 02, 2024 | 4:26 pm

ARKW

PLTR

Palantir Technologies, Inc. (NYSE:PLTR) stock has declined over 17% in the past month despite being up 150% over the past year. The company extended its partnership with the U.S. Army, with a contract valued at $115.04 million. Ark Invest, led by Cathie Wood, traded shares of Palantir, buying 1,578,738 shares and selling 101,921 shares through ARKW. Palantir's stock is currently trading above its 50-day moving average but below its 52-week high.

Portfolio Pulse from Erica Kollmann

January 02, 2024 | 4:18 pm

ALID

BBRRF

Blueberries Medical Corp. (OTC:BBRRF) announced a non-brokered private placement of 180,716,00 common shares at $0.0083 per share, raising approximately $1.99 million. The proceeds will repay debt and support general corporate purposes. The offering was led by Terraflos Inc., with plans to expand into Argentina, Mexico, and Brazil. Blueberries also has a joint venture with Allied Corp. (OTCQB:ALID) for the production of cannabis derivatives. Post-announcement, BBRRF shares rose 12.7451% to $0.0138.

Portfolio Pulse from Jelena Martinovic

January 02, 2024 | 4:10 pm

SNES

SenesTech shares have risen following the announcement of an expanded distribution agreement with Pesterminators, which now includes the deployment of Evolve and an extension of territory into the UAE.

Portfolio Pulse from Benzinga Newsdesk

January 02, 2024 | 3:43 pm

NVS

VYGR

Voyager Therapeutics Inc (VYGR) stock soared after announcing a strategic collaboration and capsid license agreement with Novartis Pharma AG, a subsidiary of Novartis AG (NVS), for gene therapies targeting Huntington's disease and spinal muscular atrophy. Voyager will license its TRACER capsids to Novartis and receive $100 million upfront, including a $20 million equity purchase, with potential for $1.2 billion in milestones and royalties. Novartis will handle development and commercialization, while Voyager focuses on preclinical advancement. VYGR shares jumped 36% to $11.48.

Portfolio Pulse from Vandana Singh

January 02, 2024 | 2:50 pm

KSCP

Knightscope, Inc. (NASDAQ:KSCP) has received an order for 13 K1 Blue Light E-Phones from its Authorized Partner TS&L for installation at Georgia State University. This is part of a larger expected order of over 50 emergency communication devices for the university's downtown Atlanta campus. The K1 E-Phones are designed to provide reliable communication in emergencies, especially when cell service is unavailable or cell phone batteries are dead.

Portfolio Pulse from Benzinga Newsdesk

January 02, 2024 | 2:40 pm

NIO

Regal Hotels International Holdings Ltd. and Cosmopolitan International Holdings Ltd. have signed a memorandum of cooperation with Saudi Arabia to develop up to 50 hotels in the Middle East, with an investment of up to $5 billion. The partnership aims to build 30 hotels in Saudi Arabia as part of the kingdom's efforts to diversify its economy away from oil. The companies will also establish an asset management platform to fund hotel-related projects. The Middle East is increasing investments in China and Hong Kong, with significant funds flowing into Chinese corporates from Middle Eastern states.

Portfolio Pulse from The Bamboo Works

January 02, 2024 | 2:34 pm